Microbot Medical granted U.S. patent that expands potential market applications

Microbot Medical (MBOT) announced that the United States Patent and Trademark Office, USPTO, has granted the Company a patent, covering a modular robotic surgical system which includes a base and a plurality of tool-receiver units arranged as separate units and independently and interchangeably attachable to the base. The Company considers the issuance of this patent to be significant, as it will potentially enable LIBERTY to be adapted in the future for a wider range of endovascular procedures, which would increase substantially the Total Addressable Market the Company is aiming to penetrate. This patent expands the Company’s intellectual property protection in the United States for its LIBERTY system portfolio, which now includes 12 patents granted globally and 57 patent applications pending.